Targeting Ongoing DNA Damage in Multiple Myeloma: Effects of DNA Damage Response Inhibitors on Plasma Cell Survival

por Herrero, Ana Belén, Gutiérrez, Norma Carmen
Publicado 2017

Synergistic effect of Chloroquine and Panobinostat in ovarian cancer through induction of DNA damage and inhibition of DNA repair

por Ovejero-Sánchez, María, González-Sarmiento, Rogelio, Herrero, Ana Belén
Publicado 2021

DNA Damage Response Alterations in Ovarian Cancer: From Molecular Mechanisms to Therapeutic Opportunities

por Ovejero-Sánchez, María, González-Sarmiento, Rogelio, Herrero, Ana Belén
Publicado 2023

FAM46C controls antibody production by the polyadenylation of immunoglobulin mRNAs and inhibits cell migration in multiple myeloma

por Herrero, Ana Belén, Quwaider, Dalia, Corchete, Luis Antonio, Mateos, Maria Victoria, García‐Sanz, Ramón, Gutiérrez, Norma C.
Publicado 2020

Factors Regulating microRNA Expression and Function in Multiple Myeloma

por Misiewicz-Krzeminska, Irena, Krzeminski, Patryk, Corchete, Luis A., Quwaider, Dalia, Rojas, Elizabeta A., Herrero, Ana Belén, Gutiérrez, Norma C.
Publicado 2019

Autophagy, Oxidative Stress, and Alcoholic Liver Disease: A Systematic Review and Potential Clinical Applications

por Salete-Granado, Daniel, Carbonell, Cristina, Puertas-Miranda, David, Vega-Rodríguez, Víctor-José, García-Macia, Marina, Herrero, Ana Belén, Marcos, Miguel
Publicado 2023

Panobinostat Synergistically Enhances the Cytotoxicity of Microtubule Destabilizing Drugs in Ovarian Cancer Cells

por Ovejero-Sánchez, María, Asensio-Juárez, Gloria, González, Myriam, Puebla, Pilar, Vicente-Manzanares, Miguel, Pélaez, Rafael, González-Sarmiento, Rogelio, Herrero, Ana Belén
Publicado 2022

Chloroquine-Induced DNA Damage Synergizes with Nonhomologous End Joining Inhibition to Cause Ovarian Cancer Cell Cytotoxicity

por Ovejero-Sánchez, María, Rubio-Heras, Jorge, Vicente de la Peña, María del Carmen, San-Segundo, Laura, Pérez-Losada, Jesús, González-Sarmiento, Rogelio, Herrero, Ana Belén
Publicado 2022

Dissecting the role of TP53 alterations in del(11q) chronic lymphocytic leukemia

por Quijada‐Álamo, Miguel, Pérez‐Carretero, Claudia, Hernández‐Sánchez, María, Rodríguez‐Vicente, Ana‐Eugenia, Herrero, Ana‐Belén, Hernández‐Sánchez, Jesús‐María, Martín‐Izquierdo, Marta, Santos‐Mínguez, Sandra, del Rey, Mónica, González, Teresa, Rubio‐Martínez, Araceli, García de Coca, Alfonso, Dávila‐Valls, Julio, Hernández‐Rivas, José‐Ángel, Parker, Helen, Strefford, Jonathan C., Benito, Rocío, Ordóñez, José‐Luis, Hernández‐Rivas, Jesús‐María
Publicado 2021